1313006
Hydralazine hydrochloride
United States Pharmacopeia (USP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 304-20-1
Synonym(S): 1-Hydrazinophthalazine hydrochloride
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 200 MG | 1313006-200-MG | In Stock | ₹ 40,756.13 |
1313006 - 200 MG
In Stock
Quantity
1
Base Price: ₹ 40,756.13
GST (18%): ₹ 7,336.103
Total Price: ₹ 48,092.233
grade
pharmaceutical primary standard
API family
hydralazine
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
SMILES string
Cl[H].N\N=C1/N=NC=C2C=CC=CC12
InChI
1S/C8H8N4.ClH/c9-11-8-7-4-2-1-3-6(7)5-10-12-8;/h1-5,7H,9H2;1H/b11-8-;
InChI key
SECXUXOCDLQOBI-MKFZHGHUSA-N
Other Options
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Hydralazine hydrochloride USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
- Biochem/physiol Actions: Inhibits DNA methyltransferase and modulates epigenetic regulation of gene expression. Non-selective MAO-A/B inhibitor; antihypertensive; semicarbazide-sensitive amine oxidase inhibitor.
- Analysis Note: These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 3 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
Target Organs
Respiratory system
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
grade: pharmaceutical primary standard
API family: hydralazine
manufacturer/tradename: USP
application(s): pharmaceutical (small molecule)
format: neat
SMILES string: Cl[H].N\N=C1/N=NC=C2C=CC=CC12
InChI: 1S/C8H8N4.ClH/c9-11-8-7-4-2-1-3-6(7)5-10-12-8;/h1-5,7H,9H2;1H/b11-8-;
InChI key: SECXUXOCDLQOBI-MKFZHGHUSA-N
grade:
pharmaceutical primary standard
API family:
hydralazine
manufacturer/tradename:
USP
application(s):
pharmaceutical (small molecule)
format:
neat
SMILES string:
Cl[H].N\N=C1/N=NC=C2C=CC=CC12
InChI:
1S/C8H8N4.ClH/c9-11-8-7-4-2-1-3-6(7)5-10-12-8;/h1-5,7H,9H2;1H/b11-8-;
InChI key:
SECXUXOCDLQOBI-MKFZHGHUSA-N
grade: __
API family: __
manufacturer/tradename: Avanti Polar Lipids
application(s): __
format: __
SMILES string: __
InChI: __
InChI key: __
grade:
__
API family:
__
manufacturer/tradename:
Avanti Polar Lipids
application(s):
__
format:
__
SMILES string:
__
InChI:
__
InChI key:
__
grade: __
API family: __
manufacturer/tradename: Avanti Polar Lipids
application(s): __
format: __
SMILES string: __
InChI: __
InChI key: __
grade:
__
API family:
__
manufacturer/tradename:
Avanti Polar Lipids
application(s):
__
format:
__
SMILES string:
__
InChI:
__
InChI key:
__
grade: __
API family: __
manufacturer/tradename: Avanti Polar Lipids
application(s): __
format: __
SMILES string: [H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCCCCCCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](OS([O-])(=O)=O)[C@H]([C@H]1CO)O.[NH4+]
InChI: __
InChI key: __
grade:
__
API family:
__
manufacturer/tradename:
Avanti Polar Lipids
application(s):
__
format:
__
SMILES string:
[H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCCCCCCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](OS([O-])(=O)=O)[C@H]([C@H]1CO)O.[NH4+]
InChI:
__
InChI key:
__